Lotrimin Ultra Antifungal Switch Approved By FDA
This article was originally published in The Tan Sheet
Executive Summary
Schering-Plough's Lotrimin Ultra will launch nationwide in the first quarter of 2002, marking the third generation of OTC athlete's foot antifungals to bear the Lotrimin name
You may also be interested in...
Schering-Plough’s “Faster” Claims For Lotrimin Ultra Not Accurate – NAD
Schering-Plough Healthcare Products should modify claims that its Lotrimin Ultra relieves athlete's foot in less time than Novartis Consumer Healthcare's Lamisil Defense, the National Advertising Division recommends
Ertaczo Topical Antifungal Will Face Stiff OTC Competition
OrthoNeutrogena's newly approved topical athlete's foot treatment Ertaczo will face an uphill marketing battle from a slew of OTC antifungals indicated for ringworm and jock itch
Schering Lotrimin Ultra Is “Ultra Powerful. Ultra Easy,” Ads State
Television ads for Schering-Plough's Lotrimin Ultra Antifungal Cream for both athlete's foot and jock itch highlight the ease and power of the product's "once-a-day" application and prescription strength ingredient